Fungal Infection Treatments Baltimore MD

A drug used to help prevent recurring breast cancer appears to hold promise as a treatment for deadly fungal infections in Baltimore.

Multi Specialty Healthcare
(410) 234-1600
1800 N Charles St
Baltimore, MD

Data Provided by:
Chengzhang Shi
(410) 905-7140
711 W. 40th St.
Baltimore, MD
Business
Cheng's Acupuncture & Herbs Clinic
Specialties
Acupuncture
Insurance
Insurance Plans Accepted: BlueCross BlueShield, EHP, United Health care, PhCS, EHP, Anthem, PHN, Kaiser
Workmens Comp Accepted: Yes
Accepts Uninsured Patients: Yes
Emergency Care: No

Doctor Information
Medical School: Union Peking Medical School/MITCM, 90/02
Additional Information
Languages Spoken: English,Chinese

Data Provided by:
Tom Ingegno M.S.O.M., L.Ac.
(410) 842-7784
715 Park Ave
Baltimore, MD
Business
Ancient Arts Acupuncture
Specialties
Acupuncture
Insurance
Insurance Plans Accepted: Blue Cross/ Blue ShieldCare FirstFederal Blue Cross/ Blue ShieldCignaUnited HealthcareAetnaMail Carriers
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: Yes
Emergency Care: No

Doctor Information
Medical School: NY College of Wholistic Health Education & Research, 2001
Additional Information
Member Organizations: NAJOM, NCCAOM, ASNY, Maryland Acupuncture Society.
Languages Spoken: English

Data Provided by:
Sheri Rowen, M.D. Laser Vision Correction
(410) 332-9500
301 Saint Paul Pl
Baltimore, MD

Data Provided by:
Camden-Inner Harbor Veterinary Services
(410) 404-1600
Camden Yards - Baltimore
Baltimore, MD

Data Provided by:
Hampden Family Chiropractic
(443) 478-2892
3617 Falls Road
Baltimore, MD

Data Provided by:
Sajeev Kathuria, MD
(410) 328-6533
419 W Redwood St
Baltimore, MD
Business
University of Maryland Eye Associates
Specialties
Ophthalmology

Data Provided by:
Marcia S Driscoll, MD
(410) 328-5823
419 W Redwood St
Baltimore, MD
Business
University of Maryland Dermatology
Specialties
Dermatology

Data Provided by:
Bernard Chang
(410) 332-9700
301 St. Paul Place
Baltimore, MD
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
DocSide Veterinary Medical Center
(410) 522-0055
1705 Bank St
Baltimore, MD

Data Provided by:
Data Provided by:

Fungal Infection Treatments

Provided By:

A drug used to help prevent recurring breast cancer appears to hold promise as a treatment for deadly fungal infections, new research has found.

University of Rochester Medical Center researchers found that tamoxifen kills yeast in mice with Candida infections, which can be fatal to people with compromised immune systems, including people with cancer or HIV and those taking immunosuppressants for chronic conditions.

At extremely high levels, tamoxifen slashed yeast levels by 150-fold, causing most fungus cells to break up and die while halting surviving cells from progressing into a disease-causing state, their study found.

"It's still early, but if tamoxifen, or molecules like it, turns out to be an effective treatment against serious fungal infections, it'll be a welcome addition to our arsenal," Dr. Damian Krysan, an assistant professor of pediatrics at the university and an author of the study, said in a university news release.

The results are published in the August issue of Antimicrobial Agents and Chemotherapy.

Available antifungal medications pose some issues for people who need them the most, according to background information in the news release. The only new class of antifungals approved for use in the past two decades is generally effective, but they can only be taken intravenously, which poses logistic and other problems for some patients. And the most common oral antifungal medication only slows fungus cell growth, making it difficult for immune-compromised patients to completely shake their infections.

"We don't have vaccines against fungal infections, and the few drugs we do have aren't always effective," Krysan said. "We've got a lot more work to do to figure out whether tamoxifen could be used in high doses or whether it could be used in combination with other treatments, but we're excited about the possibility of giving doctors another way to help these critically ill patients."

More information

The U.S. Centers for Disease Control and Prevention has more about Candidiasis.

SOURCE: University of Rochester Medical Center, news release, July 20, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com